SAFECODE DRUG TECHNOLOGIES CORP. Debt Instrument, Convertible, Beneficial Conversion Feature
SAFECODE DRUG TECHNOLOGIES CORP. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $30.50 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2013-05-10
- SAFECODE DRUG TECHNOLOGIES CORP. debt instrument, convertible, beneficial conversion feature for the quarter ending 2013-03-31 was $30.50K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month |
|---|---|
| 2013-03-31 | $30.50K 10-Q · filed 2013-05-10 |